Editorial policy
The rules we hold ourselves to, published so you can check whether we follow them. Last updated 2026-08-22.
1. Sourcing
Every factual claim traces to a primary source: the official order page, the published return policy, manufacturer-supplied artwork, or peer-reviewed literature indexed on PubMed. We do not cite other affiliate sites, brand-distributed press releases, or AI-generated summaries as evidence for a factual claim.
2. Dose verification
When a seller publishes a dose or a blend total, we compare it against the doses used in the research being cited for those ingredients and publish both figures side by side. That is the single most useful check available in this category, and it is why the dose gap exists. Where no amount is published at all, we say so rather than estimating.
3. Undisclosed means undisclosed
Where a manufacturer does not publish an amount — here, the split between the three amino acids inside the 500 mg blend — we write that it is not published. We do not estimate, infer from ingredient order, or describe an unknown quantity as though it were known.
4. Safety before benefits
On every substantive page, interaction and contraindication information appears above benefit information. Where an ingredient carries a documented concern the seller omits — the halted L-arginine trial in post-infarction patients being the clearest example here — we publish it regardless. And on a blood pressure product, the instruction never to change prescribed medication appears on every page rather than once.
5. Claims we will not repeat
We do not reproduce disease claims, unverifiable review counts, rankings with no named ranking body, or endorsements from individuals whose credentials cannot be checked. Where a seller makes such a claim, we identify it as unverifiable rather than passing it along.
6. Credit where it is due
We publish what a seller gets right alongside what it gets wrong. On this product that includes publishing the blend total, the absence of anchor pricing, correct regulatory language, an accurate mechanism description, unusually generous refund terms, and advising that the smallest package best matches the guarantee window. A reference that never credits anything is an advertisement in reverse.
7. Clinical review
Every page touching dosing, interactions, contraindications or physiological mechanism is reviewed by Dr. Halina Vrba, PharmD, BCCP before publication. Clinical review covers factual accuracy and safety framing; it is not a product endorsement and does not constitute medical advice to any reader.
8. Dating and corrections
Every page carries the date its claims were last verified. When we are shown an error we correct it, note the correction, and re-date the page. Corrections go to editorial@bloodprilstore.com and we aim to respond within five business days.
9. Commercial independence
We earn affiliate commission on purchases made through our links. No advertiser, manufacturer or affiliate network reviews our content before publication, and none has the ability to require a change to it. Our affiliate disclosure sets out the relationship in full.
10. Who we will tell not to buy
Where the evidence indicates a reader should not purchase — because of a contraindication, an interaction, or because their symptoms warrant medical assessment instead — we say so plainly, on the same page as the purchase link. A referral site that never says no is not a reference, it is an advertisement.